“…It has been proposed that NMDAR function could particularly be impaired in hippocampal and neocortical GABAergic interneurons in the disorder, compromising recurrent inhibition ( Carlén et al, 2012 ; Curley and Lewis, 2012 ; Gilmour et al, 2012 ). Two prominent GABAergic inhibitory interneuron subpopulations, defined by mutually exclusive markers parvalbumin (PV) or cholecystokinin (CCK), are strongly involved through recurrent inhibition in rhythmic network activities in the neocortex and hippocampus ( Cobb et al, 1995 ; Ellender and Paulsen, 2010 ; Manseau et al, 2010 ; Lasztóczi et al, 2011 ; Buzsáki and Wang, 2012 ; Fasano et al, 2017 ; Pelkey et al, 2017 ). Disrupted function of either of these interneuron populations in animal models results in alterations of coordinated neuronal network activities, particularly the synchronous gamma frequency (20–80 Hz) oscillations, and causes behavioral changes associated with the disorder ( Belforte et al, 2010 ; Nakazawa et al, 2012 ; Brown et al, 2014 ; Schmidt et al, 2014 ; Cho et al, 2015 ; Gonzalez-Burgos et al, 2015 ; Schmidt and Mirnics, 2015 ; Huang et al, 2016 ; Del Pino et al, 2017 ; Medrihan et al, 2017 ; Vargish et al, 2017 ).…”